This Large Cap Hospitals Stock To Be Included In Nifty Has A Buy Rating For Up To 22% Gains

This hospital stock zoomed for the second day in a row after it is slated to enter the Nifty 50 index. In today's session, the large cap hospitals stock in line with the broader markets settled higher by 5.74% at Rs. 4633.45 per share. As per the brokerage firm Edelweiss, stock's inclusion in Nifty 50 is expected to bring in inflow of $143 million from ETFs that mirror the index.

This Large Cap Hospitals Stock To Be Included In Nifty Has A Buy Rating For Up To 22% Gains

The inclusion shall be effective from February 25, 2022

Further, most brokerage houses has given the stock a 'Buy' for gains upto:

Brokerage	Target price	Upside	Rationale
Edelweiss	5500	18.70%	Focus on improved asset utilisation, strong balance sheet, omni-channel presence
Motilal Oswal	5630	21.50%	Company's foothold in distribution in the pharmacy space, product launch on Amazon
Nomura	5247	13.00%	Expansion of hospital bed capacity. Realisation of cumulative sales of $1 bn via Amazon collaboration

Disclaimer: The markets are highly choppy amid global cues. The buy rating on the given stock is given by the brokerage houses. Please take your investment call after considerable due diligence.

GoodReturns.in